Active Health DPC Resource Library

Multi-cancer early detection (MCED) blood tests, such as the Galleri test, offer the possibility of detecting multiple cancers from a single blood sample before symptoms develop. While this emerging technology is exciting, it is important to understand both its potential benefits and its limitations. Learn how these tests work, what methylation patterns are, the risks of false positives and false negatives, and why MCED testing should complement—not replace—recommended cancer screenings.

March is Colon Cancer Awareness Month What You Need to Know About Screening, Risk, and Prevention Colon cancer (also called colorectal cancer) was once thought of as a disease affecting primarily older adults, but that is changing. Over the past decade, rates have been steadily increasing in younger individuals, and many people diagnosed before age […]